STXS - Stereotaxis, Inc.
| Previous Close | 0.5800 |
| Open | 0.0000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0000 - 0.0000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 40,751 |
| Market Cap | 38.259M |
| Beta | 1.59 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3240 |
| Earnings Date | Feb 5, 2018 - Feb 9, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire•13 days ago
Stereotaxis Announces Expanded European Labeling for Navigation in the Pericardial Space
LOUIS, April 11, 2018-- Stereotaxis, Inc., the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that navigation in the pericardial space has been ...
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of STXS earnings conference call or presentation 6-Mar-18 3:00pm GMT
Q4 2017 Stereotaxis Inc Earnings Call
- GlobeNewswire•2 months ago
Stereotaxis Reports 2017 Fourth Quarter and Full Year Financial Results
7% year-over-year growth in fourth quarter global procedures and recurring revenue Substantial progress in delineating and initiating strategic innovation plans Increasing quantity and quality of peer-reviewed ...
- GlobeNewswire•2 months ago
Stereotaxis Announces $10.0 Million Non-Dilutive Financing from Early Warrant Exercise
Enables continued execution of innovation and commercial initiatives Non-dilutive to shareholders Long term lock-up agreement on exercised warrants Represents necessary first step on path to relist on ...
- ACCESSWIRE•2 months ago
The Story Behind Growth: New Report Discusses Stereotaxis and OurPet's Co. - Emerging Trends Within New Industry
NEW YORK, NY / ACCESSWIRE / March 6, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Stereotaxis Inc. ( OTCQX: STXS ) and OurPet's Co. ( OTCQX: OPCO ), ...
- GlobeNewswire•2 months ago
Stereotaxis to Report Fourth Quarter and Full Year 2017 Financial Results on March 6, 2018
LOUIS, March 02, 2018-- Stereotaxis, Inc., a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2017 ...
- GlobeNewswire•3 months ago
European Heart Rhythm Association Highlights Occupational Risk of Radiation Exposure in Electrophysiology Procedures
Stereotaxis technology included in recommendations to reduce fluoroscopy exposure and described as allowing“ near zero exposure” to electrophysiologists Clinical data demonstrates significant reduction ...
- Thomson Reuters StreetEvents•5 months ago
Edited Transcript of STXS earnings conference call or presentation 9-Nov-17 3:00pm GMT
Q3 2017 Stereotaxis Inc Earnings Call
Capital Cube•7 months agoStereotaxis, Inc. :STXS-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
Categories: Yahoo FinanceGet free summary analysis Stereotaxis, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 8.47 million, Net Earnings of USD -0.18 million. Gross margins narrowed from 86.09% to 73.99% compared to the same period last year, operating (EBITDA) margins now -2.93% from -19.07%. Change in operating cash ... Read more (Read more...)
- Thomson Reuters StreetEvents•8 months ago
Edited Transcript of STXS earnings conference call or presentation 10-Aug-17 2:00pm GMT
Q2 2017 Stereotaxis Inc Earnings Call
- ACCESSWIRE•8 months ago
Investor Network: Stereotaxis, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 10, 2017 / Stereotaxis, Inc. (NASDAQ: STXS ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, August 10, 2017 at 10:00 AM Eastern ...